SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-104095
Filing Date
2023-09-27
Accepted
2023-09-27 08:15:14
Documents
14
Period of Report
2023-09-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2326985d1_8k.htm   iXBRL 8-K 24807
2 EXHIBIT 99.1 tm2326985d1_ex99-1.htm EX-99.1 23610
6 GRAPHIC tm2326985d1_ex99-1img01.jpg GRAPHIC 17502
  Complete submission text file 0001104659-23-104095.txt   252974

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctso-20230927.xsd EX-101.SCH 3027
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctso-20230927_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctso-20230927_pre.xml EX-101.PRE 22367
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2326985d1_8k_htm.xml XML 3205
Mailing Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540 973-329-8885
Cytosorbents Corp (Filer) CIK: 0001175151 (see all company filings)

IRS No.: 980373793 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36792 | Film No.: 231281866
SIC: 3841 Surgical & Medical Instruments & Apparatus